INTERSECT ENT
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.
INTERSECT ENT
Industry:
Health Care Medical Pharmaceutical
Founded:
2003-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.intersectent.com
Total Employee:
251+
Status:
Active
Contact:
650-641-2100
Email Addresses:
[email protected]
Total Funding:
167.84 M USD
Technology used in webpage:
Mobile Non Scaleable Content IPv6 ReCAPTCHA IIS Apache 2.4 ReCAPTCHA V2 IIS 10 Microsoft Java EE Microsoft Azure
Similar Organizations
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-09-15 | Fiagon | Fiagon acquired by Intersect ENT | 60 M EUR |
Investors List
Deerfield
Deerfield investment in Post-IPO Equity - Intersect ENT
PTV Healthcare Capital
PTV Healthcare Capital investment in Series D - Intersect ENT
Harmony Partners
Harmony Partners investment in Series D - Intersect ENT
Norwest Venture Partners
Norwest Venture Partners investment in Series D - Intersect ENT
Kleiner Perkins
Kleiner Perkins investment in Series D - Intersect ENT
U.S. Venture Partners
U.S. Venture Partners investment in Series D - Intersect ENT
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Intersect ENT
Norwest Venture Partners
Norwest Venture Partners investment in Series C - Intersect ENT
PTV Healthcare Capital
PTV Healthcare Capital investment in Series C - Intersect ENT
Medtronic
Medtronic investment in Series C - Intersect ENT
Official Site Inspections
http://www.intersectent.com Semrush global rank: 1.6 M Semrush visits lastest month: 15.96 K
- Host name: cloudproxy10164.sucuri.net
- IP address: 192.124.249.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago